Share on LinkedInShare on LinkedIn

ARTICLE · 12 DECEMBER 2013

A Turducken Task: How Actavis Invites Relitigation Of Patent Merits

For decades, the antitrust and patent law regimes have hung in a delicate balance, fostering the coexisting goals of innovation and competition.

United StatesIntellectual Property

This article was first published in the December 4, 2013 issue of Westlaw Journal Pharmaceutical, December 2013 (Volume 29, Issue 10). Reprinted here with permission of Andrews Publications, a Thomson Reuters business © 2013.

For decades, the antitrust and patent law regimes have hung in a delicate balance, fostering the coexisting goals of innovation and competition. The two regimes exist as flip sides of the same coin: Patent law aims to incentivize innovation as a means to promote competition, while antitrust law promotes competition as a means to incentivize innovation. Patents reward innovators by granting them legal monopoly rights. They operate as limited exceptions to antitrust law's general prohibition of monopolies.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from